10-Mar-2008 - Alfa Laval has introduced new plate technology for the continuous production of pharmaceuticals, fine chemicals and speciality chemicals that has "the potential to start something of a revolution in the chemicals industry", the Swedish company claims.

Link to Article

in-pharmatechnologist.com

10-Mar-2008 - MedImmune is taking advantage of a new US recommendation on the immunisation of school children to almost triple production of its intranasal influenza vaccine, FluMist, for the coming 'flu season.

Link to Article

In-Pharmatechnologist.com

07-Mar-2008 - A US Food and Drug Administration (FDA) investigation into the recent Baxter heparin scare has uncovered a contaminant in the product that was sourcing the active pharmaceutical ingredient (API) from a Chinese manufacturer.

Link to Article

In-Pharmatechnologist.com

Link to Article

NYTimes.com

New labels on three medications tells of risks of death, tumors

Link to Article

MSNBC.com

Government maintains Georgia girl's case no proof of autism link

Link to Article

MSNBC.com

Decision is the third setback in recent months for new formulation

Link to Article

MSNBC.com

Despite studies’ failure to show any link between vaccines and autism, skeptics say a settlement in the case of 9-year-old Hannah Poling shows that they have been right along.

Link to Article

NYTimes.com

Link to All Articles

Mar 06 2008, 12:25 PM EST
Amgen Pays $100M Upfront for Kyowa Hakko's Inflammation and Oncology mAb
An additional $420 million is dependent on attaining development milestones of this early-stage candidate.Full Story

Mar 06 2008, 12:21 PM EST
Millipore Expands Portfolio of Animal-Free Cell Culture Supplements through Agreement with Solabia
Firm gains exclusive rights to seven plant-derived hydrolysates.Full Story

Mar 05 2008, 01:27 PM EST
Molecular Alliance Identified that Sustains Embryonic Stem-Cell State
A core Klf circuitry regulates self-renewal, according to a Nature Cell Biology paper.Full Story

Mar 05 2008, 12:50 PM EST
PanGenetics Closes Series C Round with $35M in Its Pocket
Funding will help company begin clinical development of psoriatic arthritis and chronic pain compounds.Full Story

Mar 04 2008, 11:34 AM EST
Adnavance Opens Lab to Further Its Molecular Diagnostic Platform
Facility will be used for R&D on the firm's M-DNA™ technology, which is touted to obviate target and signal amplification used in current tests.Full Story

Mar 04 2008, 11:31 AM EST
Biotage Signs Two-Year Extension of Molecular Imaging Agreement with McMaster University
Collaborators will use the Biotage Initiator on more radionuclides and probes to create novel agents.Full Story

Mar 03 2008, 12:26 PM EST
Neurobiological Technologies Allies with Buck Institute for Alzheimer's Disease Drug Development
Neurobiological will fund a three-year joint research project, with $1.2 million in the first year, and gains exclusive rights for $175,000.Full Story

Mar 03 2008, 12:24 PM EST
OneWorld Health, Amyris, and Sanofi-Aventis to Create a Complementary Source for Key Ingredient of Malaria Therapy
The goal is to develop semisynthetic artemisinin and introduce it by 2010.Full Story

Mar 03 2008, 12:39 PM EST
Pfizer to Procure Serenex for Access to Hsp90 Pipeline
Deal will add an early-stage anticancer agent, preclinical oncology and nononcology compounds, and discovery platform.Full Story

Feb 29 2008, 11:25 AM EST
Investigators Identify Human Gene that Bars HIV in Culture
Study published in PLoS Pathogens showed that TRIMM22 prevents the assembly of the virus.Full Story

GenEngNews.com